The true volatility of small-cap stocks in Canada and the pure beauty of competition that exists in our monthly Stock Challenges was on full display Monday afternoon.

There was never a definite leader throughout the entire month and only one past Stock Challenge Champ finished in the Top 10 (an anomaly in our monthly Challenge) as November’s Stock Challenge was fought with grit to the bitter end. To see just how close the Challenge was down the stretch we saved a few screen shots for you below:

November’s Stock Challenge at 12:15 pm on final day of trading:

November’s Stock Challenge at 12:45 pm on final day of trading:

Remember, the above are combined average monthly returns of each respective member’s picks. Member ‘Jacks86’ had a serious gut check at about 12:45 PM when not only member ‘jeanne54’, but member ‘GeoInvest’ jumped ahead of him.

And then, in the dying minutes of Monday’s trading action, new member ‘Jacks86’ witnessed his picks make a surge. On the final day, it came down to his selection of Ceapro, a growth-stage biotechnology company targeting the commercialization of active ingredients for healthcare and cosmetic industries, closing at the high as opposed to the low.

Ceapro closed for trading on October 30th at $0.205 per share. Within a few weeks the company’s shares would hit a high of $0.495 per share – more than doubling in value. Its stock traded more than a quarter million shares that day, rallying 34%.

Ceapro – 1 Month Chart


Ceapro: profitable healthcare stock leads to November Stock Challenge Victory

Ceapro released significant news on the 12th of this month, when it reported record sales, including the highest quarterly revenue performance in its history. What’s more, the company is profitable, an elusive goal of many tech and healthcare-related revenue generators on the TSX Venture.

In the company’s financial highlights for the 3rd quarter of 2015, the company reported:

“Net profit of $1,006,000 in 3Q 2015 vs. $690,000 in 3Q 2014.”

Click here to read all the details.

We at Pinnacle have been writing about the trend of liquidity finding tech and healthcare-related issuers on the TSX Venture and Ceapro is just another example.

In the end, Jacks86’s 51.06% combined average return on the month was not to be touched.

Pinnacle members ‘GeoInvest’ and long-time member ‘jeanne54’ who hails from Edmonton put up a valiant battle for November’s Stock Challenge crown, but ultimately fell just short of victory.

GeoInvest, with his final surge into the top spot with only minutes remaining in November’s Stock Challenge, had the victory wrestled out of his fading grip, and for this reason was the clear winner of the People’s Champ award with his 47.95% return. Good show GeoInvest!

The People’s Champ is a selective award associated with Pinnacle’s Stock Challenge, and is given to the participant who failed to win, but nonetheless made a name for himself.  It comes with no prizes and unfortunately, no glory.


November Stock Challenge Top 10


9 different TSX Venture listed stocks were selected by members who finished in the Top 10 of November’s Stock Challenge. This is a testament to not only the stock picking abilities of savvy members, but the opportunity that still exists in Canada’s small-cap space, despite the depressed nature of the resource sector.

Our champion receives the winner’s only Pinnacle Package – which includes the finest of garments fit for a champion: The Stock Challenge Champ Hoodie and a Pinnacle Digest dri-fit golf shirt (for those afternoons on the links). Wear them with pride Jacks86!


Member Jacks86 will also receive a Northwest Territorial Mint 10 ounce Silver Bar.


Congratulations to our new champion and welcome to the Stock Stars Hall of Fame! We look forward to watching you compete in future contests!

Good luck to everyone in December’s Stock Challenge, which begins tomorrow and will award two 10 ounce silver bars to our first and second place finishers.

Pinnacle Digest
November’s Stock Challenge Statistics:

Challengers: 206
Highest Return: 51.06%
Lowest Return: – 45.18%
Average Return: 2.49%
Previous Champs in the Top Twenty: 6